The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
The 2018 ESMO Clinical Practice Guidelines on hepatocellular carcinoma (HCC) are conceived to provide the standard approach to diagnosis and local and systemic treatment of HCC.
Celsion Corporation has announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the...
Medtronic announced the launch of the new Barrx 360 Express radiofrequency ablation (RFA) balloon catheter, which can help in the...
High-intensity focused ultrasound (HIFU) and plasma radiofrequency ablation (PRA) have been used to treat recurrent allergic rhinitis (AR); however, there is a lack of literature comparing the efficacy of these 2 methods. We assessed and compared the therapeutic effects of HIFU and PRA on recurrent AR.
Bristol Myers Squibb announced the Phase III CheckMate -9DW trial evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for patients with advanced hepatocellular carcinoma (HCC) who have not received prior systemic therapy met its primary endpoint of improved overall survival (OS) compared to investigator’s choice of sorafenib or lenvatinib at a pre-specified interim analysis.
Background: Fascicular ventricular tachycardia (FVT) is a common form of sustained idiopathic left ventricular tachycardia with an Asian preponderance. This...
Covieden has announced that results from a prospective, multicenter, randomized, controlled clinical trial (The SURF Trial -SUrveillance vs. RadioFrequency ablation)which...
Celsion Corporation announced that results from an independent analysis of the Company’s ThermoDox HEAT Study conducted by the National Institutes...
Medtronic announced that it has received CE (Conformité Européenne) Mark for the Affera Mapping and Ablation System, which includes the Sphere-9 Catheter and the Affera Prism-1 Mapping Software.